Ajanta Financial Statements From 2010 to 2024

Stocks . India . 
Stock . Ajanta Pharma Limited
AJANTPHARM   2,960  14.55  0.49%   
Ajanta Pharma financial statements provide useful quarterly and yearly information to potential Ajanta Pharma Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ajanta Pharma financial statements helps investors assess Ajanta Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ajanta Pharma's valuation are summarized below:
Gross Profit
26.9 B
Profit Margin
0.1948
Market Capitalization
369.8 B
Enterprise Value Revenue
8.1584
Revenue
44.9 B
We have found eighty-nine available fundamental signals for Ajanta Pharma Limited, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Ajanta Pharma Limited prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.

Ajanta Pharma Total Revenue

44.19 Billion

Check Ajanta Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ajanta Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 83.5 M or Selling And Marketing Expenses of 42.7 M, as well as many indicators such as . Ajanta financial statements analysis is a perfect complement when working with Ajanta Pharma Valuation or Volatility modules.
  
This module can also supplement various Ajanta Pharma Technical models . Check out the analysis of Ajanta Pharma Correlation against competitors.

Ajanta Pharma Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets48.7 B46.4 B25 B
Slightly volatile
Short and Long Term Debt Total335.2 M352.8 M582.7 M
Slightly volatile
Total Current Liabilities9.4 B9 B4.7 B
Slightly volatile
Total Stockholder Equity37.5 B35.7 B19.2 B
Slightly volatile
Property Plant And Equipment Net18.1 B17.2 B10.4 B
Slightly volatile
Cash910.1 M1.3 B1.1 B
Slightly volatile
Non Current Assets Total20 B19.1 B11.4 B
Slightly volatile
Cash And Short Term Investments4.8 B4.6 B2.6 B
Slightly volatile
Common Stock Shares Outstanding104.9 M126 M129.2 M
Slightly volatile
Liabilities And Stockholders Equity48.7 B46.4 B25 B
Slightly volatile
Non Current Liabilities Total973.4 M1.8 B971.3 M
Slightly volatile
Inventory8.7 B8.3 B4.3 B
Slightly volatile
Total Liabilities11.2 B10.7 B5.8 B
Slightly volatile
Total Current Assets28.7 B27.3 B13.6 B
Slightly volatile
Common Stock173.1 M251.8 M174.1 M
Slightly volatile
Retained Earnings37 B35.3 B13.3 B
Slightly volatile
Net Receivables6.5 B12.5 B5.7 B
Slightly volatile
Intangible Assets95.3 M146.6 M91 M
Very volatile
Accounts Payable2.8 B4.6 B2.4 B
Slightly volatile
Short Term Debt111.7 M117.6 M336.3 M
Slightly volatile
Other Liabilities1.5 B1.4 B723.1 M
Slightly volatile
Net Tangible Assets21.1 B37.4 B18.8 B
Slightly volatile
Other Assets797.3 M1.3 B716.8 M
Slightly volatile
Short Term Investments1.8 B3.3 B1.4 B
Slightly volatile
Long Term Investments138.4 M117 M124.8 M
Very volatile
Short and Long Term Debt14.2 M14.9 M435.8 M
Slightly volatile
Property Plant Equipment12.7 B19.5 B10.6 B
Slightly volatile
Long Term Debt Total316.4 M301.3 M154 M
Slightly volatile
Net Invested Capital31.7 B35.7 B25.1 B
Slightly volatile
Net Working Capital14.5 B18.4 B11.2 B
Slightly volatile
Capital Stock220.3 M290.6 M190.9 M
Slightly volatile
Capital Lease Obligations330.1 M337.9 M297.7 M
Slightly volatile
Property Plant And Equipment Gross16.1 B17.2 B20.2 B
Slightly volatile

Ajanta Pharma Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 B1.4 B768.2 M
Slightly volatile
Interest Expense83.5 M72.1 M76.6 M
Pretty Stable
Selling And Marketing Expenses42.7 M44.9 M1.7 B
Very volatile
Total Revenue44.2 B42.1 B22.1 B
Slightly volatile
Gross Profit11.8 B21.1 B14.2 B
Slightly volatile
Other Operating Expenses12.2 B22.4 B14.4 B
Slightly volatile
Operating Income20.7 B19.7 B6.9 B
Slightly volatile
EBIT11.8 B11.2 B6 B
Slightly volatile
EBITDA13.2 B12.6 B6.8 B
Slightly volatile
Cost Of Revenue22.1 B21 B7.2 B
Slightly volatile
Total Operating Expenses32 B30.5 B11.9 B
Slightly volatile
Income Before Tax11.7 B11.1 B5.9 B
Slightly volatile
Net Income8.6 B8.2 B4.4 B
Slightly volatile
Research Development1.5 B2.1 B1.3 B
Slightly volatile
Selling General Administrative9.5 B9.1 B1.5 B
Slightly volatile
Net Income From Continuing Ops5.6 B8.2 B4.5 B
Slightly volatile
Net Income Applicable To Common Shares5.2 B6.8 B4.4 B
Slightly volatile
Tax Provision2 B3 B1.7 B
Slightly volatile
Interest Income305.3 M277.1 M244.1 M
Slightly volatile
Reconciled Depreciation1.2 B1.4 B845.1 M
Slightly volatile

Ajanta Pharma Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.5 B3.3 B1.1 B
Slightly volatile
Depreciation1.4 B1.4 B769.5 M
Slightly volatile
Dividends Paid6.7 B6.4 B1.4 B
Slightly volatile
Capital Expenditures1.5 B1.5 B1.7 B
Slightly volatile
Net Income4.2 B8.2 B5.2 B
Slightly volatile
End Period Cash Flow840.8 M1.3 B1 B
Slightly volatile
Stock Based Compensation57.6 M54.9 M11.8 M
Slightly volatile

Ajanta Fundamental Market Drivers

Cash And Short Term Investments4.6 B

About Ajanta Pharma Financial Statements

Investors use fundamental indicators, such as Ajanta Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ajanta Pharma's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue393.2 M373.5 M
Total Revenue42.1 B44.2 B
Cost Of Revenue21 B22.1 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Other Information on Investing in Ajanta Stock

Ajanta Pharma financial ratios help investors to determine whether Ajanta Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ajanta with respect to the benefits of owning Ajanta Pharma security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY